Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionDeutsche Bank Ag\
Latest Disclosed Ownership8,385 shares
Latest Disclosed Value $ 338,000
Deutsche Bank Ag\ reports 0.72% decrease in ownership of HTD / Corcept Therapeutics Incorporated

On May 6, 2026 - Deutsche Bank Ag\ filed a 13F-HR form disclosing ownership of 8,385 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $289,199 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 8,446 shares of Corcept Therapeutics Incorporated. This represents a change in shares of -0.72% during the quarter. The current value of the position is $530,267 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 8,385 -61 -0.72 338 15.36 0.0001
2026-02-11 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 8,446 279 3.42 294 -56.78 0.0001
2025-11-13 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 8,167 833 11.36 679 26.02 0.0002
2025-08-12 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 7,334 -59,701 -89.06 538 -92.97 0.0002
2025-05-09 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 67,035 -6,565 -8.92 7,657 106.47 0.0030
2025-06-30 2024-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 73,600 24,051 48.54 3,709 61.71 0.0015
2025-02-14 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 73,600 24,051 3,709 0.0014
2025-06-26 2024-09-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 49,549 10,619 27.28 2,293 81.41 0.0009
2024-11-13 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 49,549 10,619 2,293 0.0009
2025-06-12 2024-06-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 38,930 -12,872 -24.85 1,265 -3.07 0.0006
2024-08-14 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 38,930 -12,872 1,265 0.0006
2025-06-02 2024-03-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 51,802 7,524 16.99 1,305 -9.32 0.0006
2024-05-15 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 51,802 7,524 1,305 0.0006
2024-02-14 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 44,278 -687 -1.53 1,438 17.39 0.0007
2023-11-24 2023-09-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 44,965 5,134 12.89 1,225 38.26 0.0008
2023-11-09 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 44,965 5,134 1,225 0.0007
2023-08-14 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 39,831 -22,793 -36.40 886 -34.66 0.0005
2023-05-15 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 62,624 17,501 38.79 1,356 48.03 0.0008
2023-02-13 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 45,123 6,671 17.35 916 -7.10 0.0005
2022-11-14 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 38,452 -9,358 -19.57 986 -13.28 0.0006
2022-08-11 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 47,810 -10,132 -17.49 1,137 -12.87 0.0006
2022-05-13 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 57,942 -10,668 -15.55 1,305 -3.90 0.0006
2022-02-16 2021-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 68,610 -301,217 -81.45 1,358 -81.34 0.0006
2022-02-11 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 68,610 -301,217 1,358 0.0001
2021-11-04 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 369,827 -22,047 -5.63 7,279 -15.58 0.0035
2021-08-11 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 391,874 18,671 5.00 8,622 -2.88 0.0042
2021-05-13 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 373,203 -35,427 -8.67 8,878 -16.95 0.0048
2021-02-16 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 408,630 -102,111 -19.99 10,690 20.26 0.0065
2020-11-12 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 510,741 -382,867 -42.85 8,889 -40.86 0.0061
2020-08-13 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 893,608 10,063 1.14 15,030 43.07 0.0114
2020-05-14 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 883,545 821,578 1,325.83 10,505 1,304.41 0.0094
2020-02-14 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 61,967 -95,144 -60.56 748 -66.29 0.0005
2019-11-14 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 157,111 -80,105 -33.77 2,219 -16.01 0.0015
2019-08-14 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 237,216 75,719 46.89 2,642 39.57 0.0016
2019-05-15 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 161,497 16,953 11.73 1,893 -1.87 0.0011
2019-04-01 2018-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 144,544 -250,432 -63.40 1,929 -65.17 0.0014
2019-02-14 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 144,544 -181,601 1,929
2021-12-21 2018-09-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 394,976 -95,232 -19.43 5,538 -28.13 0.0028
2018-11-14 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 326,145 -164,063 4,570 0.0032
2020-04-21 2018-06-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 490,208 -291,372 -37.28 7,706 -40.05 0.0038
2018-08-14 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 294,338 -487,242 4,625 3,071.9135
2019-10-23 2018-03-31 13F/A-2 CORCEPT THERAPEUTICS COM 218352102 781,580 556,505 247.25 12,855 216.47 0.0061
2019-10-18 2018-03-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 781,580 0 12,855 0.0061
2018-05-15 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 526,064 300,989 8,651
2018-02-14 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 225,075 5,372 2.45 4,062 -4.15 0.0026
2017-11-14 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 219,703 93,599 74.22 4,238 185.00 0.0029
2017-08-11 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 126,104 107,440 575.65 1,487 632.51 0.0011
2017-05-15 2017-03-31 13F CORCEPT THERAPEUTICS COM 218352102 18,664 -30,110 -61.73 203 -42.49 0.0001
2017-02-14 2016-12-31 13F CORCEPT THERAPEUTICS COM 218352102 48,774 23,406 92.27 353 115.24 0.0003
2016-11-14 2016-09-30 13F CORCEPT THERAPEUTICS COM 218352102 25,368 13,951 122.19 164 164.52 0.0001
2016-08-15 2016-06-30 13F CORCEPT THERAPEUTICS COM 218352102 11,417 -5,772 -33.58 62 -22.50 0.0000
2016-05-16 2016-03-31 13F CORCEPT THERAPEUTICS COM 218352102 17,189 -9,249 -34.98 80 -38.46 0.0001
2016-02-16 2015-12-31 13F CORCEPT THERAPEUTICS COM 218352102 26,438 -75,551 -74.08 130 -66.06 0.0001
2015-11-17 2015-09-30 13F CORCEPT THERAPEUTICS COM 218352102 101,989 -82,300 -44.66 383 -65.37 0.0003
2015-08-12 2015-06-30 13F CORCEPT THERAPEUTICS COM 218352102 184,289 120,224 187.66 1,106 208.94 0.0007
2015-05-15 2015-03-31 13F CORCEPT THERAPEUTICS COM 218352102 64,065 19,200 42.80 358 169.17 0.0002
2015-02-13 2014-12-31 13F CORCEPT THERAPEUTICS COM 218352102 44,865 1,374 3.16 133 14.66 0.0001
2014-11-14 2014-09-30 13F CORCEPT THERAPEUTICS COM 218352102 43,491 -29,522 -40.43 116 -43.14 0.0001
2014-08-15 2014-06-30 13F CORCEPT THERAPEUTICS COM 218352102 73,013 -17,162 -19.03 204 -47.96 0.0001
2014-05-15 2014-03-31 13F CORCEPT THERAPEUTICS COM 218352102 90,175 11,949 15.27 392 56.18 0.0003
2014-02-24 2013-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 78,226 -98,741 -55.80 251 -10.36 0.0002
2014-02-18 2013-12-31 13F CORCEPT THERAPEUTICS COM 218352102 78,226 251
2013-11-18 2013-09-30 13F CORCEPT THERAPEUTICS COM 218352102 176,967 79,967 82.44 280 68.67 0.0002
2013-08-16 2013-06-30 13F CORCEPT THERAPEUTICS COM 021835210 97,000 97,000 166 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.